Mass spectrometric quantitation of peptides and proteins using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA).
A method (denoted SISCAPA) for quantitation of peptides in complex digests is described. In the method, anti-peptide antibodies immobilized on 100 nanoliter nanoaffinity columns are used to enrich specific peptides along with spiked stable-isotope-labeled internal standards of the same sequence. Upon elution from the anti-peptide antibody supports, electrospray mass spectrometry is used to quantitate the peptides (natural and labeled). In a series of pilot experiments, tryptic test peptides were chosen for four proteins of human plasma (hemopexin, alpha1 antichymotrypsin, interleukin-6, and tumor necrosis factor-alpha) from a pool of 10,203 in silico tryptic peptide candidates representing 237 known plasma components. Rabbit polyclonal antibodies raised against the chosen peptide sequences were affinity purified and covalently immobilized on POROS supports. Binding and elution from these supports was shown to provide an average 120-fold enrichment of the antigen peptide relative to others, as measured by selected ion monitoring (SIM) or selected reaction monitoring (SRM) electrospray mass spectrometry. The columns could be recycled with little loss in binding capacity, and generated peptide ion current measurements with cycle-to-cycle coefficients of variation near 5%. Anti-peptide antibody enrichment will contribute to increased sensitivity of MS-based assays, particularly for lower abundance proteins in plasma, and may ultimately allow substitution of a rapid bind/elute process for the time-consuming reverse phase separation now used as a prelude to online MS peptide assays. The method appears suitable for rapid generation of assays for defined proteins, and should find application in the validation of diagnostic protein panels in large sample sets.
Anderson
N Leigh
NL
Plasma Proteome Institute, PO Box 53450, Washington, DC 20009-3450, USA. leighanderson@plasmaproteome.org
Anderson
Norman G
NG
Haines
Lee R
LR
Hardie
Darryl B
DB
Olafson
Robert W
RW
Pearson
Terry W
TW
D000888:Antibodies, Anti-Idiotypic / Q000737:chemistry*; D001798:Blood Proteins / Q000737:chemistry; D002846:Chromatography, Affinity; D002853:Chromatography, Liquid; D006241:Haptens / Q000737:chemistry; D006466:Hemopexin / Q000737:chemistry; D006801:Humans; D015850:Interleukin-6 / Q000737:chemistry; D007477:Ions; D013058:Mass Spectrometry / Q000379:methods*; D036103:Nanotechnology; D010455:Peptides / Q000737:chemistry*; D017434:Protein Structure, Tertiary; D011506:Proteins / Q000737:chemistry*; D021241:Spectrometry, Mass, Electrospray Ionization; D013997:Time Factors; D014409:Tumor Necrosis Factor-alpha / Q000737:chemistry; D000514:alpha 1-Antichymotrypsin / Q000737:chemistry
D000888:Antibodies, Anti-Idiotypic; D001798:Blood Proteins; D006241:Haptens; D015850:Interleukin-6; D007477:Ions; D010455:Peptides; D011506:Proteins; D014409:Tumor Necrosis Factor-alpha; D000514:alpha 1-Antichymotrypsin; D006466:Hemopexin